---
title: "KARPF DAVID B — Ownership Dossier"
canonical: https://whiteintel.dev/entity/c09faf60-e9c2-5ff0-bef4-b57615c8863a
json: https://whiteintel.dev/api/public/dossier/c09faf60-e9c2-5ff0-bef4-b57615c8863a
identifier: sec:0001622067
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# KARPF DAVID B

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001622067`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/c09faf60-e9c2-5ff0-bef4-b57615c8863a  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/c09faf60-e9c2-5ff0-bef4-b57615c8863a  

## Ownership & control

### Holdings / subsidiaries

- **LUMOS PHARMA, INC.** (officer) — https://whiteintel.dev/entity/64076a09-cab0-5d69-bb5e-15a5eca2d879

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **KARPF DAVID B**. Human view: https://whiteintel.dev/entity/c09faf60-e9c2-5ff0-bef4-b57615c8863a · Structured JSON: https://whiteintel.dev/api/public/dossier/c09faf60-e9c2-5ff0-bef4-b57615c8863a._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._